Literature DB >> 10440921

Multiple biological responses activated by nuclear protein kinase C.

A M Martelli1, N Sang, P Borgatti, S Capitani, L M Neri.   

Abstract

Protein kinase C is a family of serine-threonine kinases that are physiologically activated by a number of lipid cofactors and are important transducers in many agonist-induced signaling cascades. To date, 12 different isozymes of this kinase have been identified and are believed to play distinct regulatory roles. Protein kinase C was thought to reside in the cytosol in an inactive conformation and translocate to the plasma membrane upon cell activation by different stimuli. Nevertheless, a growing body of evidence has illustrated that this family of isozymes is capable of translocating to other cellular sites, including the nucleus. Moreover, it seems that some protein kinase C isoforms are resident within the nucleus. A wealth of data is being accumulated, demonstrating that nuclear protein kinase C isoforms are involved in the regulation of several critical biological functions such as cell proliferation and differentiation, neoplastic transformation, and apoptosis. In this review, we will discuss the most significant findings concerning nuclear protein kinase C which have been published during the past 5 years. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440921

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  18 in total

1.  Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells.

Authors:  Luca M Neri; Roberta Bortul; Paola Borgatti; Giovanna Tabellini; Giovanna Baldini; Silvano Capitani; Alberto M Martelli
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

2.  The specificity of the protein kinase C alpha, betaII and gamma isoforms as assessed by an unnatural alcohol-appended peptide library.

Authors:  X Yan; K Curley; D S Lawrence
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

3.  A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.

Authors:  Yazmin Odia; Joohee Sul; Joanna H Shih; Teri N Kreisl; John A Butman; Fabio M Iwamoto; Howard A Fine
Journal:  CNS Oncol       Date:  2016-02-10

4.  Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells.

Authors:  M Mao; X Fang; Y Lu; R Lapushin; R C Bast; G B Mills
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

Review 5.  Protein kinase C in the immune system: from signalling to chromatin regulation.

Authors:  Pek Siew Lim; Christopher Ray Sutton; Sudha Rao
Journal:  Immunology       Date:  2015-10-06       Impact factor: 7.397

6.  A(1) adenosine receptor-mediated PKC and p42/p44 MAPK signaling in mouse coronary artery smooth muscle cells.

Authors:  Habib R Ansari; Bunyen Teng; Ahmed Nadeem; Kevin P Roush; Karen H Martin; J Schnermann; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-10       Impact factor: 4.733

7.  Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.

Authors:  Beverly A Teicher; Krishna Menon; Enrique Alvarez; Chuan Shih; Margaret M Faul
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

8.  A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.

Authors:  Yazmin Odia; Fabio M Iwamoto; Argirios Moustakas; Tyler J Fraum; Carlos A Salgado; Aiguo Li; Teri N Kreisl; Joohee Sul; John A Butman; Howard A Fine
Journal:  J Neurooncol       Date:  2015-12-07       Impact factor: 4.130

9.  Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure.

Authors:  Hong-Fang Mei; Neha Poonit; Yi-Chun Zhang; Chu-Yuan Ye; Hui-Lin Cai; Chen-Yi Yu; Yong-Hai Zhou; Bei-Bei Wu; Jun Cai; Xiao-Hong Cai
Journal:  Mol Cell Biochem       Date:  2018-01-29       Impact factor: 3.396

10.  Microtubule-dependent subcellular redistribution of the transcriptional coactivator p/CIP.

Authors:  Majdi S Qutob; Rabindra N Bhattacharjee; Elisa Pollari; Siu Pok Yee; Joseph Torchia
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.